Usage: BELSOMRA® (suvorexant) is indicated for treating insomnia, specifically for individuals who have trouble with sleep onset and/or sleep maintenance.
Usage: DELSTRIGO® is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg, either as a complete regimen for those with no prior antiretroviral treatment or to replace the current regimen in patients who are virologically suppressed with no history of treatment failure.
Usage: DIFICID® is indicated for treating Clostridioides difficile-associated diarrhea (CDAD) in adults and children aged 6 months and older. It should be used only for infections proven or strongly suspected to be caused by C. difficile to reduce drug-resistant bacteria development.